Mizoribine monophosphate – CAS 62025-48-3

Mizoribine monophosphate – CAS 62025-48-3 is synthesised by Sigut Labs (Prague, Czech Republic).

Purity (LC-MS)

97%+

Package contents

Mizoribine monophosphate Et3NH+ salt

This compound is for research use only. We do not sell to patients.

 

Amount
1 mg
€ 3700

Stock

Do you want custom amount?
Custom amount
Amount
1 mg
€ 3700

Stock

Do you want custom amount?
Custom amount

Characterisation

CAS: 62025-48-3, 174498-85-2 (Na+)
IUPAC name: [(2R,3S,4R,5R)-5-(4-carbamoyl-5-hydroxyimidazol-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate
Other names: bredinin monophosphate; MZB monophosphate  
Molecular weight: 339.20 g/mol
Molecular formula: C9H14N3O9P
InChI: InChI=1S/C9H14N3O9P/c10-7(15)4-8(16)12(2-11-4)9-6(14)5(13)3(21-9)1-20-22(17,18)19/h2-3,5-6,9,13-14,16H,1H2,(H2,10,15)(H2,17,18,19)/t3-,5-,6-,9-/m1/s1

Description

Mizoribine monophosphate is the metabolite of drug Mizoribine (brand name Bredinin) that is used as an immunosuppressive drug. Mizoribine (MZB) is an imidazole nucleoside that has been used in renal transplantation, and in steroid-resistant nephrotic syndrome, IgA nephropathy, lupus, as well as for adults with rheumatoid arthritis, lupus nephritis and other rheumatic diseases

Chemicals are distributed worldwide

Buy Mizoribine monophosphate now, and get your order in 48 hours

  • Shipping through DHL in 48 hours
  • Sensitive compounds are shipped on dry ice
  • All compounds are safely and rigorously packed

Payment

  • Payment terms 30 days net
  • We are sending the invoice the same day as the shipment
  • We are able to modify the invoice for the academic institution, so the order can be paid from grants

References

  • Yokota, S. (2002). Mizoribine: mode of action and effects in clinical use. Pediatrics international44(2), 196-198.
  • Turka, L. A., Dayton, J., Sinclair, G., Thompson, C. B., & Mitchell, B. S. (1991). Guanine ribonucleotide depletion inhibits T cell activation. Mechanism of action of the immunosuppressive drug mizoribine. The Journal of clinical investigation87(3), 940-948.
bg molecul blue light

Didn't find the chemical you were looking for?

Contact us
Contact
Kryštof

Get in touch

Krystof Sigut, CEO and Founder

WHY CHOOSE
SigutLabs

Your impossible is our starting line

Located in Prague, Czech Republic, EU
Versatile, seasoned all-PhD team
Global delivery with Silicon Valley clients
Open communication, reliable approach
Verifying quality of all produced substances
95% shipments delivered within 2 days

Partners & distributors

logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner
logo partner